Cargando…

The impact of sarcopenia and myosteatosis on postoperative outcomes in patients with inflammatory bowel disease

BACKGROUND: Inflammatory bowel disease (IBD) is a relatively common disorder with significant associated morbidity. Sarcopenia and myosteatosis are associated with adverse postoperative outcomes. This study investigated outcomes in IBD patients undergoing surgical resection relative to the presence...

Descripción completa

Detalles Bibliográficos
Autores principales:	O’Brien, Stephen, Kavanagh, Richard G., Carey, Brian W., Maher, Michael M., O’Connor, Owen J., Andrews, Emmet J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6246753/ https://www.ncbi.nlm.nih.gov/pubmed/30460523 http://dx.doi.org/10.1186/s41747-018-0072-3

Ejemplares similares

Sarcopenia and Post-Operative Morbidity and Mortality in Patients with Gastric Cancer
por: O'Brien, Stephen, et al.
Publicado: (2018)

Review of the role of abdominal imaging in irritable bowel syndrome
por: Kavanagh, Richard G, et al.
Publicado: (2018)

High prevalence of sarcopenia and myosteatosis in patients undergoing hemodialysis
por: Fu, Chen, et al.
Publicado: (2023)

Psoriasis Is Associated With Myosteatosis but Not Sarcopenia: A Case-Control Study
por: Chen, Xiaomei, et al.
Publicado: (2021)

Effects of sarcopenia and myosteatosis are alleviated in reduced port surgery for diverticulitis
por: Schaffler-Schaden, Dagmar, et al.
Publicado: (2023)

Myosteatosis as a Shared Biomarker for Sarcopenia and Cachexia Using MRI and Ultrasound
por: Lortie, Jevin, et al.
Publicado: (2022)

Prognostic Value of Sarcopenia and Myosteatosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma
por: Kim, Dong Wook, et al.
Publicado: (2022)

Corrigendum: Myosteatosis as a Shared Biomarker for Sarcopenia and Cachexia Using MRI and Ultrasound
por: Lortie, Jevin, et al.
Publicado: (2022)

The effect of computed tomography parameters on sarcopenia and myosteatosis assessment: a scoping review
por: Lortie, Jevin, et al.
Publicado: (2022)

Sarcopenia and myosteatosis are accompanied by distinct biological profiles in patients with pancreatic and periampullary adenocarcinomas
por: Stretch, Cynthia, et al.
Publicado: (2018)

Sarcopenia and Myosteatosis at Presentation Adversely Affect Survival After Esophagectomy for Esophageal Cancer
por: Srpcic, Matevz, et al.
Publicado: (2020)

Sarcopenia and Myosteatosis as Prognostic Markers in Patients with Advanced Cholangiocarcinoma Undergoing Palliative Treatment
por: Jördens, Markus S., et al.
Publicado: (2021)

Using body mass index to estimate individualised patient radiation dose in abdominal computed tomography
por: O’Neill, Siobhan, et al.
Publicado: (2018)

Diagnosing sarcopenia and myosteatosis based on chest computed tomography images in healthy Chinese adults
por: Tan, Lingling, et al.
Publicado: (2021)

Impact of myopenia and myosteatosis on postoperative outcome and recurrence in Crohn’s disease
por: Pozios, Ioannis, et al.
Publicado: (2022)

Sarcopenia and Myosteatosis Are Associated with Neutrophil to Lymphocyte Ratio but Not Glasgow Prognostic Score in Colorectal Cancer Patients
por: Aro, Raila, et al.
Publicado: (2022)

Minimization of Radiation Exposure due to Computed Tomography in Inflammatory Bowel Disease
por: Mc Laughlin, Patrick D., et al.
Publicado: (2012)

Are Sarcopenia and Myosteatosis in Elderly Patients with Pelvic Ring Injury Related to Mortality, Physical Functioning and Quality of Life?
por: Banierink, Hester, et al.
Publicado: (2021)

Relationship between sarcopenia/myosteatosis and frailty in hospitalized patients with cirrhosis: a sex-stratified analysis
por: Feng, Hongjuan, et al.
Publicado: (2021)

Defining sarcopenia and myosteatosis: the necessity for consensus on a technical standard and standardized cut‐off values
por: Westenberg, Lisa B., et al.
Publicado: (2022)

Sarcopenia and myosteatosis diagnostic tool for gastrointestinal cancer: creatinine to cystatin C ratio as evaluation marker
por: Liu, Hao, et al.
Publicado: (2023)

Impact of sarcopenia and myosteatosis on survival outcomes for patients with head and neck cancer undergoing curative-intent treatment
por: Ahern, Elizabeth, et al.
Publicado: (2023)

Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity
por: Kim, Hong-Kyu, et al.
Publicado: (2023)

Sarcopenia and Myosteatosis Assessed by Magnetic Resonance Enterography May Predict Negative Outcomes in Patients with Crohn’s Disease
por: Eren Cankurtaran, Rasim, et al.
Publicado: (2023)

The Prognostic Value of Sarcopenia and Myosteatosis in Biliary Tract Cancer After Palliative Treatment With Radiation-Emitting Metallic Stent
por: Chen, Qi, et al.
Publicado: (2022)

Contributory roles of sarcopenia and myosteatosis in development of overt hepatic encephalopathy and mortality after transjugular intrahepatic portosystemic shunt
por: Yin, Liang, et al.
Publicado: (2023)

Low-Dose Computed Tomography for the Optimization of Radiation Dose Exposure in Patients with Crohn's Disease
por: Kavanagh, Richard G., et al.
Publicado: (2018)

Emerging treatments for inflammatory bowel disease
por: Hazel, Karl, et al.
Publicado: (2020)

Fast acquisition abdominal MRI study for the investigation of suspected acute appendicitis in paediatric patients
por: James, Karl, et al.
Publicado: (2020)

Myosteatosis rather than sarcopenia associates with non‐alcoholic steatohepatitis in non‐alcoholic fatty liver disease preclinical models
por: Nachit, Maxime, et al.
Publicado: (2020)

Impact of Sarcopenia and Myosteatosis in Non-Cirrhotic Stages of Liver Diseases: Similarities and Differences across Aetiologies and Possible Therapeutic Strategies
por: Cespiati, Annalisa, et al.
Publicado: (2022)

Radiological assessment of skeletal muscle index and myosteatosis and their impact postoperative outcomes after liver transplantation
por: Petric, Miha, et al.
Publicado: (2023)

The Role of Sarcopenia and Myosteatosis in Short- and Long-Term Outcomes Following Curative-Intent Surgery for Hepatocellular Carcinoma in a European Cohort
por: Meister, Franziska Alexandra, et al.
Publicado: (2022)

Myosteatosis and nlr as predictors of poor outcomes in patients with Covid-19
por: Padilha, D.M.D.H., et al.
Publicado: (2021)

Sarcopenia in Inflammatory Bowel Disease: A Narrative Overview
por: Dhaliwal, Amritpal, et al.
Publicado: (2021)

Computed Tomography-Derived Myosteatosis and Metabolic Disorders
por: Miljkovic, Iva, et al.
Publicado: (2021)

Clinical Relevance of Myopenia and Myosteatosis in Colorectal Cancer
por: Okugawa, Yoshinaga, et al.
Publicado: (2022)

Body Composition of Patients Undergoing Radical Cystectomy for Bladder Cancer: Sarcopenia, Low Psoas Muscle Index, and Myosteatosis Are Independent Risk Factors for Mortality
por: Engelmann, Simon U., et al.
Publicado: (2023)

The Presence of Myosteatosis Is Associated with Age, Severity of Liver Disease and Poor Outcome and May Represent a Prodromal Phase of Sarcopenia in Patients with Liver Cirrhosis
por: Geladari, Eleni, et al.
Publicado: (2023)

Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis
por: Montano‐Loza, Aldo J., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_598iogvj241f9nssq0i9cc47gh